PGRP-S promotes hepatocellular carcinoma progression via MAPK/ERK pathway by interaction with TTC1
Abstract Abnormal expression of PGRP-S plays an important role in the development and progression of hepatocellular carcinoma (HCC), although the mechanism has remained elusive. In this study, we aimed to investigate the biological function and potential mechanism of PGRP-S in HCC. We found that PGR...
Saved in:
| Main Authors: | Huifang Zhu, Shuang Feng, Sizhen Lv, Di Zhao, Xuanhe Chang, Shangqian Fan, Xia Wang, Xinlai Qian |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-12160-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MUC3A promotes the progression of cholangiocarcinoma through the MAPK/ERK pathway
by: Baijie Feng, et al.
Published: (2025-04-01) -
Discussion on the Development of Integrated and Intelligent Space TTC&OC Network
by: Wei ZHANG, et al.
Published: (2021-06-01) -
MAPK/ERK signaling pathway in rheumatoid arthritis: mechanisms and therapeutic potential
by: Jun Xie, et al.
Published: (2025-07-01) -
The antineoplastic effects of nuciferine on hepatocellular carcinoma are associated with suppression of the HER2-AKT/ERK1/2 signaling pathway
by: Tiantian Li, et al.
Published: (2025-05-01) -
Case Report: Prenatal diagnosis of gastrointestinal defects and immunodeficiency syndrome caused by compound heterozygous mutations in TTC7A gene
by: Shuning Han, et al.
Published: (2025-08-01)